Epstein-Barr virus in Hodgkin's disease: The example of central Tunisia;Virus d'Epstein-Barr et maladie de Hodgkin: L'exemple du centre Tunisien

Annales de Pathologie

Volumn 22, Issue 2, 2002, Pages 96-101

  Korbi, Sadok ^a   Trimeche, Mounir ^a   Sriha, Badreddine ^a   Yacoubi, Mohamed Tahar ^a   Hmissa, Sihem ^a   Mokni, Moncef ^a   Delvenne, Philippe ^b   Boniver, Jacques ^b   Rammeh, Soumaya ^a  

^a FARHAT HACHED HOSPITAL   (Tunisia)

^b CHU SART TILMAN   (Belgium)

Author keywords

Epstein Barr virus; Hodgkin's disease; Immunohistochemistry; In situ hybridization

Indexed keywords

LATENT MEMBRANE PROTEIN 1;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHILD; FEMALE; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; VIRUS INFECTION;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; PREVALENCE; TUNISIA; VIRAL MATRIX PROTEINS;

EID: 0036242175     PISSN: 02426498     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Relation of Burkitt's tumor associated herpes-type virus to mononucleosis
2. Virus particules in cultured lymphoblasts from Burkitt's lymphoma
3. Epstein-Barr virus DNA in biopsies of Burkitt's tumors and anaplastic carcinomas of the nasopharynx
4. Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/DNA and viral DNA/DNA hybridation
5. Non-Hodgkin's lymphomas in never married men in Los Angeles
6. Epstein-Barr virus-DNA, in tissues of Hodgkin's disease
7. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma
8. Epstein-Barr virus in B-cell non Hodgkin's lymphomas: Unexpected infection patterns and different infection incidence in low and high grade types
9. Epstein-Barr virus genome in non-Hodgkin's lymphomas occurring in immunocomptent patients: Highest prevalence in nonlymphoblastic T-cell lymphoma and correlation with a poor prognosis
10. Detection of Epstein-Barr virus nucleic acid sequences and protein in nodal T-cell lymphomas: Relation between latent membrane protein-1 positivity and clinical course
11. Specific association of Epstein-Barr virus with lymphoepithelial carcinoma among tumors and tumorlike lesions of the salivary gland
12. Lymphoepithelioma-like carcinoma of the lung
13. Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration
14. In situ detection of Epstein-Barr virus in gastric and colorectal adenocarcinomas
15. Monoclonal Epstein-Barr virus genomes but lack of EBV-related protein expression in different types of gastric carcinoma
16. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells
17. Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus
18. Epidemiologic patterns of Hodgkin's disease
19. A Epstein-Barr virus-associated Hodgkin's disease: Epidemiologic characteristics in international data
20. Epstein-Barr virus in Hodgkin disease relation to age and subtype
21. High incidence of Epstein-Barr virus genomes in Hodgkin's disease
22. Epstein-Barr virus in Hodgkin's disease patients in Japan
23. Correlation of the expression of Epstein-Barr virus-latent membrane protein and in situ Hybridization with biotinylated Barn HI-W probes in Hodgkin's disease
24. High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of Hodgkin's disease occuring in Peru
25. Epstein-Barr virus and childhood Hodgkin's disease in Honduras and the United States
26. Hodgkin's disease in Mexico. Prevalence of Epstein-Barr virus sequences and correlations with histologic subtype
27. High prevalence of a 30-base pair deletion in the Epstein-Barr virus (EBV) latent membrane protein 1 gene and of strain type B EBV in Mexican classical Hodgkin's disease and reactive lymphoid tissue
28. Detection of Epstein-Barr virus genomes in Hodgkin's disease: Relation to age
29. Epstein-Barr virus in tumours
30. Epstein-Barr virus and Hodgkin's disease: Further evidence for the three disease hypothesis
31. Effect of Epstein-Barr virus infection on response to chemotherapy and survival in Hodgkin's disease
32. Adverse clinical outcome in Hodgkin's disease is associated with loss of retinoblastoma protein expression, high Ki67 proliferation index, and absence of Epstein-Barr virus-latent membrane protein 1 expression
33. Epstein-Barr virus association in classical Hodgkin's disease provides survival advantage to patients and correlates with high expression of proliferation markers in Reed-Sternberg cells
34. Assessment of the prognostic impact of the Epstein-Barr virus-encoded latent membrane protein 1 expression in Hodgkin's disease
35. Epstein-Barr Virus and survival after Hodgkin disease in a population-based series of women
36. Phenotypic modulation of Hodgkin and Reed-Sternberg with Epstein-Barr virus
37. The expression of the EBV Latent Membrane Protein (LMPI) is independent of CD23 and bc12 in Reed-Sternberg cells in Hodgkin's disease
38. Influence of Epstein-Barr virus encoded latent membrane protein 1 on the expression of CD23 antigen, ICAM-1 and LFA-3 in Hodgkin and Reed-Sternberg cells. A morphometric analysis